Open access
111
Views
20
CrossRef citations to date
0
Altmetric
Review
A review of omalizumab for the management of severe asthma
Ching-Hsiung Lin1 Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, Republic of China;2 Department of Respiratory Care, College of Health Sciences, Chang Jung Christian University, Tainan, Taiwan, Republic of China;3 School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Republic of China
& Shih-Lung Cheng4 Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan, Republic of China;5 Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli City, Taoyuan County, Taiwan, Republic of ChinaCorrespondence[email protected]
Pages 2369-2378
|
Published online: 26 Jul 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.